Rapid rescreening of cervical smears as a quality control method

被引:18
作者
Cross, PA
机构
[1] Queen Elizabeth Hospital, Gateshead
[2] Queen Elizabeth Hopital, Sheriff Hill
关键词
cervical smears; internal quality control; false negatives; rapid rescreening;
D O I
10.1111/j.1365-2303.1997.tb00588.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The use of a rapid rescreening method as part of an internal quality control programme is reported. During a 12-month period 33 976 smears were reviewed (90.9% of total workload). Two-hundred and nineteen reports were altered, with 23 dyskaryotic smears identified, a false-negative rate of 0.07%, a false-negative dyskaryotic rate of 1.7%. Smears reported as dyskaryotic were also subjected to the rapid screening method (with 86.8% correctly identified) as well as using the method to assess smears before the usual primary screen (with 67.2% of dyskaryotic smears correctly identified). Rapid rescreening as a quality control method is effective, and although it has limitations, should replace 10% proportional rescreening as the preferred daily quality control method of choice.
引用
收藏
页码:79 / 84
页数:6
相关论文
共 12 条
[1]   ROLE OF RE-SCREENING OF CERVICAL SMEARS IN INTERNAL QUALITY-CONTROL [J].
BAKER, A ;
MELCHER, D ;
SMITH, R .
JOURNAL OF CLINICAL PATHOLOGY, 1995, 48 (11) :1002-1004
[2]   RAPID CERVICAL CYTOLOGY SCREENING [J].
BAKER, A ;
MELCHER, DH .
CYTOPATHOLOGY, 1991, 2 (06) :299-301
[3]   Internal quality assurance in cervical cytology - One laboratory's experience [J].
Cross, PA .
CYTOPATHOLOGY, 1996, 7 (01) :25-31
[4]   RAPID RESCREENING OF CERVICAL SMEARS - AN IMPROVED METHOD OF QUALITY-CONTROL [J].
DUDDING, N .
CYTOPATHOLOGY, 1995, 6 (02) :95-99
[5]   PARTIAL RESCREENING OF ALL NEGATIVE SMEARS - AN IMPROVED METHOD OF QUALITY ASSURANCE IN LABORATORIES UNDERTAKING CERVICAL SCREENING [J].
FARAKER, CA .
CYTOPATHOLOGY, 1993, 4 (01) :47-50
[6]  
FARMERY E, 1994, ASSESSING QUALITY ME
[7]   CERVICAL (PAP) SMEAR - NEW DIRECTIONS [J].
KOSS, LG .
CANCER, 1993, 71 (04) :1406-1412
[8]  
KREIGER P, 1994, ACTA CYTOL, V38, P291
[9]  
*ROYAL COLL OBST G, 1987, REP INT WORK PART CE